Integrin cytoplasmic tails regulate integrin activation including an increase in integrin affinity for ligands. Although there is ample evidence that the membrane-proximal regions of the α and β tails interact with each other to maintain integrins in a low-affinity state, little is known about the role of the membrane-distal region of the α tail in regulation of integrin activation. We report a critical sequence for regulation of integrin activation in the membranedistal region of the αIIb tail. Alanine substitution of the RPP residues in the αIIb tail rendered αIIbβ3 constitutively active in a metabolic energy-dependent manner. Although an αIIb/α6Aβ3 chimaeric integrin, in which the αIIb tail was replaced by the α6A tail, was in an energy-dependent active state to bind soluble ligands, introduction of the RPP sequence into the α6A tail inhibited binding of an activation-dependent antibody PAC1. In αIIb/α6Aβ3, deleting the TSDA sequence from the α6A tail or single amino acid substitutions of the TSDA residues inhibited αIIb/α6Aβ3 activation and replacing the membrane-distal region of the αIIb tail with TSDA rendered αIIbβ3 active, suggesting a stimulatory role of TSDA in energy-dependent integrin activation. However, adding TSDA to the αIIb tail containing the RPP sequence of the membrane-distal region failed to activate αIIbβ3. These results suggest that the RPP sequence after the GFFKR motif of the αIIb tail suppresses energy-dependent αIIbβ3 activation. These findings provide a molecular basis for the regulation of energy-dependent integrin activation by α subunit tails.
INTRODUCTION
Integrins are α/β heterodimeric receptors, which mediate cell adhesion and signalling [1, 2] . A fundamental function of integrins is ligand binding, which is rapidly and precisely regulated by a process referred to as 'inside-out signalling' or 'integrin activation' [3] . Transduction of intracellular signals to cytoplasmic domains of integrins leads to conformational changes in the extracellular domains that result in changes of the integrin affinity for ligands [4] [5] [6] . The cytoplasmic tails of integrin α and β subunits play a pivotal role in this process [7] .
Integrin αIIbβ3 has served as a prototype for analysis of integrin activation [8] . The αIIb tail has a GFFKR sequence in its membrane-proximal region and this motif is conserved among all integrin α subunits. Deletion or mutation of the GFFKR sequence renders αIIbβ3 constitutively active [9, 10] . The GFFKR sequence and its flanking region in the αIIb tail bind calcium integrin-binding protein and ancient ubiquitous protein 1 [11, 12] , and the interaction with the former protein activates αIIbβ3 [13] . The membrane-proximal regions of αIIb and β3 cytoplasmic tails form α helical structures and resemble the two-stranded coiledcoil structure in which multiple hydrophobic and electrostatic interactions connect each other [14] [15] [16] . These findings suggest that the interaction between the membrane-proximal regions of αIIb and β3 tails constrain αIIbβ3 in a default low-affinity state and perturbation of this interaction results in αIIbβ3 activation.
In addition to the membrane-proximal region, previous studies suggest that the membrane-distal region after the GFFKR sequence in the αIIb tail also regulates the affinity state of αIIbβ3. A lipid-modified peptide containing the membrane-distal sequence (RPPLEED) penetrates the platelet membrane and inhibits agonist-induced αIIbβ3 activation [17] , whereas a membraneproximal heptapeptide (KVGFFKR) induces αIIbβ3 activation Abbreviations used: CHO, Chinese-hamster ovary; GAIP, Gα-interacting protein; GIPC, GAIP-interacting protein, C-terminus; TIP-2, tax interaction protein clone 2. 1 To whom correspondence should be addressed (e-mail takahato@m.ehime-u.ac.jp). [18] . A double mutation P998A (Pro 998 → Ala)/P999A in the αIIb tail renders αIIbβ3 constitutively active to bind soluble ligands [19] . Although these findings suggest the involvement of the membrane-distal region of the αIIb tail in αIIbβ3 activation, a molecular basis for regulation of integrin activation by this region remains to be established.
In the present study, we conducted site-directed mutagenesis of the membrane-distal region of the αIIb tail, and examined the activation states of mutant αIIbβ3. Using a model of metabolic energy-dependent αIIbβ3 activation, we found the novel sequence critical for regulation of integrin activation in the αIIb tail.
MATERIALS AND METHODS

Monoclonal antibodies and plasmids
PAC1, a monoclonal antibody specific for an active conformation of αIIbβ3 [20] , was a gift from Dr S. J. Shattil (The Scripps Research Institute, La Jolla, CA, U.S.A.). 4B10 is a non-functionblocking anti-αIIbβ3 complex-specific monoclonal antibody produced in our laboratory [21] . Human αIIb, αIIb/α6A and β3 cDNAs were also provided by Dr S. J. Shattil. The αIIb/α6A cDNA encodes the extracellular and transmembrane domains of the αIIb subunit connected to the cytoplasmic domain of the α6A subunit [22] .
Site-directed mutagenesis
PCR with mutagenic primers was used to create cDNAs with amino acid sequence substitutions, deletions and additions. Substitutions were introduced into the tail sequences of αIIb and αIIb/α6A cDNAs by the PCR using primers containing the desired mutations or by using a Quik Change site-directed mutagenesis kit (Stratagene, La Jolla, CA, U.S.A.). Deletion mutants of the α6A tail sequence were generated from the αIIb/α6A cDNA template by the PCR using a common 5 -primer containing an EcoRI restriction site and a 3 -primer containing a stop codon and an XbaI restriction site. Additional mutants containing the TSDA sequence were generated from the αIIb or αIIb/α6A cDNA template by the PCR using a common 5 -primer containing an EcoRI site and a 3 -primer containing the nucleotide sequence encoding TSDA residues followed by a stop codon and an XbaI site. The amplified PCR products were digested with EcoRI-XbaI and cloned into a mammalian expression vector pCDNA3 (Invitrogen, Carlsbad, CA, U.S.A.). The nucleotide sequences of the inserts were confirmed by sequence analysis. The amino acids in the αIIb/α6A chimaeric subunit were numbered sequentially from the N-terminus of the αIIb sequence.
Expression of recombinant integrins
Mutated αIIb or αIIb/α6A cDNA was co-transfected with wildtype β3 cDNA into CHO (Chinese-hamster ovary) cells using LIPOFECTAMINE TM (Invitrogen) or effectene (Qiagen, Tokyo, Japan), according to the manufacturer's instructions. Then the cells were cultured in Dulbecco's modified Eagle's medium containing 10 % (v/v) foetal calf serum for 48 h to achieve expression of recombinant integrins on the cell surfaces.
PAC1-binding assay
PAC1 is an anti-αIIbβ3 monoclonal IgM antibody and recognizes only an active form of αIIbβ3 [20] . PAC1 contains an RYD tract in its heavy-chain hypervariable region 3 (H-CDR3) and behaves like RGD-containing macromolecular ligands [23] . We used PAC1 to probe the activation states of αIIbβ3 mutants. CHO cells were suspended at 1.5 × 10 7 cells/ml in Tyrode's buffer containing 137 mM NaCl, 12 mM NaHCO 3 , 2.6 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 5 mM Hepes, 5.5 mM glucose and 1 mg/ml BSA (pH 7.4). In the energy-depletion experiments, cells were suspended in glucose-free Tyrode's buffer containing 4 mg/ml 2-deoxy-D-glucose and 0.2 % sodium azide and preincubated for 30 min at room temperature (22 • C). Aliquots of each cell suspension were incubated for 30 min at room temperature with a saturating amount of PAC1 IgM (0.4 % PAC1 ascites at a final concentration) and 5 µg/ml biotin-labelled 4B10 IgG in the presence of 2 mM RGDS peptide or buffer. RGDS peptide at this concentration can inhibit PAC1 binding completely [24] . Cells were then washed and resuspended in a mixture of a 1:20 dilution of FITC-conjugated goat anti-mouse IgM antibody (Biosource, Calmarillo, CA, U.S.A.) and a 1:50 dilution of phycoerythrin-streptavidin (Molecular Probes, Eugene, OR, U.S.A.) for 25 min on ice. Then 1 µl of 1 mg/ml propidium iodide (Sigma) was added. After 5 min, the cells were washed and resuspended in 500 µl of ice-cold Tyrode's buffer and analysed on a FACSCalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ, U.S.A.). After electronic compensation, PAC1 binding (FL1) was analysed on the gated subset of live cells (propidium iodide-negative, FL3) that were positive for αIIbβ3 expression (FL2).
RESULTS
Mutation of the RPP sequence in the αIIb tail renders αIIbβ3 active in an energy-dependent manner αIIbβ3 is maintained in an inactive state probably by interaction between αIIb and β3 tails. To explore residues critical for regulation of αIIbβ3 activation in the membrane-distal region of the αIIb tail, we applied alanine-scanning mutagenesis to all residues after the GFFKR sequence, and tested these mutants for PAC1 binding ( Figure 1A ). As the double mutation P998A/P999A was reported to activate αIIbβ3, this mutant was included as a positive control [19] . The R995D mutant within the GFFKR sequence was included as another positive control [10] . Surface expression of αIIbβ3 was determined by flow cytometry using a non-function-blocking anti-αIIbβ3 monoclonal antibody 4B10 [21] . The mutants tested were expressed on the surface of CHO cells to 75-152 % of wild-type αIIbβ3 ( Figure 1B ). Then binding of PAC1 to CHO cells expressing αIIbβ3 mutants was examined. Specific-PAC1 binding was defined as that which was inhibited by the RGDS peptide and was expressed relative to the amount of αIIbβ3 on the cell surfaces, which was determined simultaneously using 4B10. 4B10 did not compete with PAC1 for binding to αIIbβ3 (results not shown). Among all the mutations of the membrane-distal residues, only the R997A and P998A/P999A mutations showed significant PAC1 binding, implying activation of αIIbβ3 by mutation of the 997 RPP sequence ( Figure 1C ). The αIIbβ3 mutant, in which the RPP sequence was substituted with a reversed sequence (PPR), was constitutively active ( Figure 1C ). These results suggest that the RPP sequence in the αIIb tail is involved in the regulation of αIIbβ3 activation.
In our assay using a transient transfection system, as shown in Figure 1 (C), the R997A mutation showed a stronger phenotype when compared with the P998A/P999A mutation, but a weaker phenotype when compared with the R995D mutation, with respect to the ability to activate αIIbβ3. A distinctive feature of the R995D mutation is that αIIbβ3 activation by this mutation is independent of metabolic energy [22] . To see whether activation of the RPP sequence mutants was dependent on metabolic energy or not, these mutants were pretreated with 2-deoxy-D-glucose and sodium azide to inhibit oxidative metabolism and then tested for PAC1 binding. The R997A and P998A/P999A mutants showed decreased PAC1 binding under conditions of energy depletion (Figure 2) . A similar result was obtained with the PPR mutant. In contrast, this treatment had no effect on PAC1 binding to the R995D mutant. These results suggest that mutation of the membrane-distal region of the αIIb tail activates αIIbβ3 through a mechanism distinct from that of the membrane-proximal region.
An RPP sequence inhibits activation of αIIb/α6Aβ3 chimaeric integrin
To explore further the regulatory effect of the RPP sequence on metabolic energy-dependent αIIbβ3 activation, we took advantage of an αIIb/α6Aβ3 chimaeric integrin in which the αIIb cytoplasmic tail was replaced with the α6A tail. This integrin is constitutively active in a metabolic energy-dependent manner [22, 25, 26] . Since the α6A tail has no RPP sequence ( Figure 4A ), we assumed that the absence of RPP sequence in the α6A tail might be responsible for αIIb/α6Aβ3 activation. To test this idea, we generated αIIb/α6Aβ3 mutant in which the 997 KKD sequence was substituted with the 997 RPP sequence in the αIIb/α6A tail. This substitution strongly inhibited PAC1 binding, although the mutant integrin was sufficiently expressed on the cell surface ( Figure 3) . Substitution with an inversed sequence PPR had no Our results with RPP mutations suggest an inhibitory role of the RPP sequence in αIIbβ3 activation. However, a previous mutational study showed that deletion of the RPP sequences from the αIIb tail (αIIb 996) keeps αIIbβ3 in an inactive state (Figure 6 and [22] ), implying that loss of the RPP sequence from the αIIb tail is not sufficient for spontaneous αIIbβ3 activation. This result may be due to total loss of the membrane-distal region, which may comprise an energy-dependent integrin activation system. Since the membrane-proximal KXGFFKR sequence is conserved between αIIb and α6A tails, we reasoned that some membrane-distal residue of the α6A tail might have a stimulatory role in αIIb/α6Aβ3 activation. To identify such residues, we produced a series of αIIb/α6Aβ3 mutants with truncated α6A tails. The truncation mutants tested were expressed on the surface of CHO cells to 98-196 % of intact αIIb/α6Aβ3 ( Figure 4B ). As expected, intact αIIb/α6Aβ3 exhibited marked PAC1 binding. Although the αIIb/α6A 1024, 1023 and 1022 deletions inhibited PAC1 binding slightly, αIIb/α6A 1021 deletion and more proximal deletions decreased PAC1 binding to a low level comparable with that of an inactive form of wild-type αIIbβ3 (Figure 4C ). This result indicates that deletion of the TSDA sequence from the C-terminus of the α6A tail disrupts αIIb/α6Aβ3 activation ( Figures 4A and 4C) . When all the deletion mutants were stimulated with an anti-αIIbβ3 activating monoclonal antibody, PT25-2 [27] , they bound PAC1 as well as wild-type αIIbβ3 (results not shown), eliminating the possibility that long-range propagation of these mutations directly causes conformational disruption of an extracellular ligand-binding pocket.
We examined the effects of amino acid substitutions within the TSDA sequence on PAC1 binding. Substitution of a single residue with alanine or glutamine inhibited PAC1 binding significantly, whereas substitution of the Arg 1019 residue outside the TSDA sequence with alanine had no effect ( Figure 5 ). Substituting the TSDA sequence with an inverse sequence (ADST) caused significant inhibition. These results with TSDA-deletion and substitution mutants suggest that the TSDA sequence in the membrane-distal region of the α6A tail is critical for αIIb/α6Aβ3 activation, in addition to the absence of the RPP sequence from the α6A tail. We next examined whether replacement of the αIIb membranedistal region by the TSDA sequence activates αIIbβ3. We produced αIIb 996TSDA, an αIIbβ3 mutant in which the membranedistal region of the αIIb tail after the GFFKR sequence was replaced by the TSDA sequence. The αIIb 996 deletion alone did not activate αIIbβ3, as reported previously [22] . In contrast, αIIb 996TSDA was in a constitutively active state to bind PAC1, although it bound less PAC1 when compared with αIIb/α6Aβ3 ( Figure 6 ). To determine whether activation of this mutant requires metabolic energy as well as that of αIIb/α6Aβ3, αIIb 996TSDA was pretreated with 2-deoxy-D-glucose and sodium azide and then tested for PAC1 binding. αIIb 996TSDA showed reduced PAC1 binding under conditions of energy depletion, as did αIIb/α6Aβ3 ( Figure 7) ; αIIbR995D had no effect. These results indicate that the αIIb 996TSDA mutant represents another model of metabolic energy-dependent αIIbβ3 activation.
An RPP sequence in the αIIb tail is critical for suppression of energy-dependent αIIbβ3 activation
We employed αIIb 996TSDA to explore the role of the membrane-distal region of the αIIb tail in energy-dependent αIIbβ3 activation. αIIb 996TSDA was obtained by adding TSDA to the αIIb tail lacking the membrane-distal region, and αIIbβ3 bearing this mutation was active. However, the addition of TSDA to the whole αIIb tail (αIIbTSDA) did not activate αIIbβ3 (Figure 6 ), despite adequate surface expression levels (results not shown). These results suggest that the membrane-distal region after the Arg 995 residue in the αIIb tail suppresses TSDA-induced αIIbβ3 activation. To identify critical residues for suppression of αIIbβ3 activation in the αIIb tail, we produced a series of αIIbβ3 mutants in which the TSDA sequence was added to the C-terminus of the αIIb tail, containing residues after Arg 995 , and examined PAC1 binding to these mutants. The αIIb 1000 mutant containing the 996 NRPP sequence was not activated by adding TSDA (Figure 8 ). The αIIb 998 mutant was partially activated by TSDA and the αIIb 997 mutant containing 996 N, but not 997 RPP, was activated by TSDA to the same extent as the αIIb 996 mutant. The αIIb/α6A 1000 mutant containing the same length of sequence as the αIIb 1000 mutant was activated by TSDA. These results indicate that the 997 RPP sequence of the αIIb tail exerts dominant inhibition of TSDA-induced αIIbβ3 activation. This finding is consistent with the foregoing results showing the suppressive effects of the RPP sequence on αIIbβ3 and αIIb/α6Aβ3 activation and, thus, it is suggested that the RPP sequence in the αIIb tail is critical for suppression of energydependent αIIbβ3 activation.
DISCUSSION
Identification of amino acid sequences critical for integrin activation and signalling in the cytoplasmic domains has contributed to our understanding of the structural basis of integrin functions. The GFFKR sequence in integrin α tails and the NPXY motif in β tails have been identified as indispensable sites for integrin activation and signalling [28] [29] [30] . In the integrin αIIbβ3, the GFFKR forms a structural constraint that locks αIIbβ3 in a default low-affinity conformation. The NPXY motif directly interacts with a signalling adaptor protein Shc and two cytoskeletal proteins myosin and talin, and these interactions are essential for bidirectional signalling [30, 31] . In the present study, we found that the RPP sequence in the αIIb tail serves as a suppressor of energydependent αIIbβ3 activation. The RPP sequence lies at the αIIb membrane-distal region following the GFFKR, and no functional motif has been identified in this region. The RPP sequence is conserved among αIIb, αV and α8 subunits. The corresponding sequences in αL, αM, αX and αD are (Y/L)K(E/D), indicating sequence homology among α partners with β2 subunit. Therefore this membrane-distal region of the α tails following GFFKR may be one of the structural determinants regulating integrin activation.
Recent NMR analyses of the peptides containing the entire αIIb tail sequence revealed that the N-terminal 991 GFFKRNRPP residues form an α helix, terminating at Pro 999 , followed by a turn, which allows a closed conformation with the C-terminal loop to fold back towards the N-terminal helix [14, 15] . Results from our study suggest that the RPP sequence of the αIIb tail, as well as the GFFKR sequence, plays a suppressive role in αIIbβ3 activation. However, in contrast with the metabolic energy-independent activation of αIIbβ3 by GFFKR mutations, activation of αIIbβ3 by RPP mutations was metabolically energy dependent. These findings suggest that the RPP sequence maintains αIIbβ3 in a low-affinity state through a mechanism distinct from that of the conserved GFFKR motif, even though both sequences are within the same α helix structure. Vinogradova et al. [14] proposed a hypothetical model of αIIbβ3 activation in which conformational changes in the position of the 998 PP residues open the closed conformation between the N-terminal helix and C-terminal loop of the αIIb tail and thus allow access of some integrin activator to the αIIbβ3 tails. This model may explain the metabolic energydependent activation of αIIbβ3 by RPP mutations we observed. Recently, Tadokoro et al. [32] reported that knockdown of talin expression reduced energy-dependent integrin activation and that specific binding of talin to the membrane-distal residues of the integrin β tails led to integrin activation in an energy-dependent manner. Therefore it is probable that metabolic energy is required for regulation of this binding. Conformational changes in the RPP region of the α tails may allow talin to bind to β tails. In this context, it would be intriguing to determine whether talin knockdown reduces energy-dependent activation of the RPP mutant integrins.
In the present study, we used a chimaeric integrin αIIb/α6Aβ3 as a model of metabolic energy-dependent activation of αIIbβ3. This integrin has been employed as a useful tool for studies on integrin signalling and molecular cloning of intracellular proteins involved in integrin activation [21, 22, 25, 26, [33] [34] [35] [36] . However, the mechanism of αIIb/α6Aβ3 activation remains poorly defined. Previous studies revealed that αIIb/α6Aβ3 activation requires metabolic energy and is inhibited by overexpression of the isolated integrin β1 or β3 tail, suggesting the involvement of some intracellular component(s) in the process that activates this integrin [22, 25] . The present study suggests that the absence of the RPP sequence and the presence of the TSDA sequence in the α6A tail are involved in αIIb/α6Aβ3 activation in an energy-dependent manner. Moreover, our result suggests that the presence of RPP inhibited TSDA-induced αIIbβ3 activation and indicates that the inhibitory function of RPP predominates over the stimulatory function of TSDA. These findings raise the possibility that αIIb/ α6Aβ3 activation is induced by interaction of TSDA with some intracellular protein(s) concerned with integrin activation, which is prevented if the α tail contains RPP which interacts with the β3 tail or other protein(s). A previous study showed that replacing the αIIb tail by an α2, α5 or α6B tail also renders αIIbβ3 constitutively active, whereas replacing by αV does not [22] . These effects are correlated with the absence or presence of the RPP sequence in the α tails replaced. Moreover, the C-terminal TSDA sequence of the α6A tail was recently reported to correspond to a type I PDZ recognition motif and to bind a PDZ-containing cytoplasmic protein TIP-2 (tax interaction protein clone 2)/GIPC [GAIP (Gα-interacting protein)-interacting protein, C-terminus] [37, 38] . Proteins of this family function as scaffold proteins for the assembly of signalling complexes [39] and TIP-2/GIPC may tether glucose transporter 1 to the cytoskeleton [40] . The α5 tail also contains the TSDA sequence in its C-terminus and binds TIP-2/GIPC [37, 38] . The α6B tail can bind TIP-2/GIPC although it does not contain a conserved PDZ recognition sequence [37, 38] . The αIIb/α5β3 and αIIb/α6Bβ3 chimaeric integrins expressed in CHO cells are constitutively active [22] and TIP-2/GIPC is expressed by CHO cells [40] . Although these results raise the possibility that TIP-2/GIPC participates in the process of integrin activation, the differential effects of TSDA mutations on TIP-2/GIPC binding and αIIb/α6Aβ3 activation do not support this. Substituting a serine or aspartate residue within the TSDA sequence with alanine and deleting the SDA sequence inhibited binding of TIP-2/GIPC to the α6A tail completely [37] , whereas the same mutations inhibited PAC1 binding to αIIb/α6Aβ3 by 20-60 %, as shown in the present study (Figures 4 and 5) . Moreover, although αIIb/α2β3 is constitutively active [22] , TIP-2/GIPC did not bind to the α2 tail [37, 38] . However, these findings do not exclude the possibility that the interaction between TSDA and TIP-2/GIPC is one of the pathways to integrin activation and that the TSDA sequence interacts with as yet unknown intracellular proteins involved in integrin activation. Further studies will be required to identify components essential for αIIb/α6Aβ3 activation and to determine the physiological significance of such components.
Evidence that integrin activation is regulated by an interaction between α and β tails is increasing [10, [15] [16] [17] 41, 42] , although this interaction was not detected under certain conditions [43, 44] . The membrane-proximal regions of the α and β tails interact with each other to keep integrins in a low-affinity state and integrin activation is probably brought about by the removal of α cytoplasmic tail constraints from the β tail [10, 16, 41] . As for the membrane-distal regions, Ginsberg et al. [17] recently proposed that the 997 RPPLEED region of the αIIb tail contacts the β3 tail to maintain αIIbβ3 in a low-affinity state. This is consistent with our results for the 997 RPP mutations, although the 1000 LEED mutations failed to activate αIIbβ3 ( Figure 1C) . Interestingly, another partner with the β3 subunit, αV, has the RPP, but not the LEED, sequence in the corresponding position of the αIIb tail. Therefore it would be intriguing to determine whether the RPP sequence of the αV tail interacts with the β3 tail to suppress αVβ3 activation. Our preliminary results showed that αVβ3 was activated by RPP mutations (J. Yamanouchi and T. Hato, unpublished work). Identification of these cytoplasmic tail sequences as regulators of integrin activation will help to unravel the molecular basis for energy-dependent integrin activation.
